National and Kapodistrian University of Athens
Η έκφραση του παράγοντα PPAR-γ (Peroxisome Proliferator Activated Receptor gamma) σε ασθενείς με καρκίνο του παχέος εντέρου και η σημασία του στην πρόγνωση
Abstract
dc:descriptionColorectal cancer is one of the primary causes of cancer-related mortality in the Western world. Recent advances in the understanding of colorectal cancer have raised expectations that this knowledge might lead to cancer prevention. In this view the identification of genetic alterations that underline the initiation of colorectal tumors and the drugs that prevent colorectal tumors' formation show practical promise. Τhus, we studied the correlation between PPARγ, a nuclear receptor that is strongly related to the thyroid and retinoid receptors to colon cancer. We examined the expression of PPARγ in 89 patients with colon cancer, using immunohistochemistry and we correlated it with histopathological parameters (Ki 67 labelling index) and molecules related to cell cycle (Rb protein) and patients' survival. In our study, positive PPAR-γ immunostaining was prominent in 47 out of 89 cases of colon cancer (53%). No association was found for PPAR-γ positivity between the different Dukes' stage, histological grade of differentiation, tumor location, presence of lymph node and liver metastasis, venous invasion and tumor cells proliferating capacity assessed as Ki-67 overexpression. On the contrary, PPAR-γ expression was statistically significantly correlated with the expression of cell cycle related molecules,such as pRb, cyclin D1 and Cdk-inhibitors p16 and p21, presenting also a trend for cyclin E, in the examined cases of human colon cancer. The pattern of PPAR-γ staining observed in the present study was mainly cytoplasmic and nuclear, and less frequently cytoplasmic only, while nuclear pattern of staining was noted in only one out of 47 positive colon carcinoma cases. The fact that the expression of PPARγ in the examined cases of colon cancer was not related to either tumor stage, or differentiation or patients' survival but to proteins regulating positively or negatively the cell cycle, reinforces the hypothesis that this receptor contributes to carcinogenesis in colon. Further experimental in vitro and in vivo studies are necessary to explore the PPARγ participation and the potential of therapeutic implication of PPARγ agonists in the treatment of colon cancer.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Soukouli, Paraskevi
- Σούκουλη, Παρασκευή
Subjects
dc:subject × 11Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/18087